Provided is an orally disintegrable tablet that shows a high stability of active ingredients [acetylsalicylic acid and a proton pump inhibitor (PPI)] and stably and quickly exerts the pharmacological effects of the active ingredients after dosing. A multiple unit-type orally disintegrable tablet that comprises enteric microgranules containing acetylsalicylic acid, enteric microgranules containing a PPI and additives, wherein an enteric coating layer of the enteric microgranules containing acetylsalicylic acid contains an aqueous enteric polymer base and a sustained-release base.
